Previous Page   Next Page

The content of this section has been developed in collaboration between COR2ED GmbH (an Independent Medical Education Company) and the experts serving as Scientific Directors on this programme:

  • Dr. Andrea Sartore-Bianchi, Ospedale Niguarda Ca' Granda, Italy.
  • Prof. Fernando Lopez-Rios, Hospital Universitario, Sanchinarro, Spain.
  • Assoc. Prof. Gerald Prager, Medical University of Vienna, Austria.
  • Dr. Jaclyn Hechtman, Memorial Sloan Kettering Cancer Center, USA.

Medical writing support was provided by Mark English, PhD, and Tricia Newell, PhD, of COR2ED GmbH. Subsequently the content was donated to the European Society for Medical Oncology (ESMO).

ESMO, COR2ED GmbH and the Scientific Directors wish to thank Bayer for their support with an Independent Medical Grant. Within the context of this Independent Medical Grant Bayer had no influence over the content.

ESMO only accepts content from third parties after careful evaluation of its educational and scientific relevance to the ESMO target audience. Eligible material should meet the essential criterion of non-promotional intent. Such material may be published in other resources, but the content donor has given permission to ESMO for use in OncologyPRO.

The creation of this content has largely been compiled from expert statements, literature review (of review articles, reports of small cohort studies and limited data from small prospective, randomised clinical trials) and expert guidance from the Scientific Directors as listed above.

Last update: 24 June 2019